JP2022545916A5 - - Google Patents

Info

Publication number
JP2022545916A5
JP2022545916A5 JP2022513150A JP2022513150A JP2022545916A5 JP 2022545916 A5 JP2022545916 A5 JP 2022545916A5 JP 2022513150 A JP2022513150 A JP 2022513150A JP 2022513150 A JP2022513150 A JP 2022513150A JP 2022545916 A5 JP2022545916 A5 JP 2022545916A5
Authority
JP
Japan
Prior art keywords
compound
trp
sar
peg3
analogy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022513150A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022545916A (ja
JP7711044B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2020/073905 external-priority patent/WO2021037942A1/en
Publication of JP2022545916A publication Critical patent/JP2022545916A/ja
Publication of JP2022545916A5 publication Critical patent/JP2022545916A5/ja
Application granted granted Critical
Publication of JP7711044B2 publication Critical patent/JP7711044B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022513150A 2019-08-27 2020-08-26 コンプスタチン類似体及びその医学的使用 Active JP7711044B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP19193925.5 2019-08-27
EP19193925 2019-08-27
EP20172189.1 2020-04-29
EP20172189 2020-04-29
PCT/EP2020/073905 WO2021037942A1 (en) 2019-08-27 2020-08-26 Compstatin analogues and their medical uses

Publications (3)

Publication Number Publication Date
JP2022545916A JP2022545916A (ja) 2022-11-01
JP2022545916A5 true JP2022545916A5 (https=) 2023-09-04
JP7711044B2 JP7711044B2 (ja) 2025-07-22

Family

ID=72178552

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022513150A Active JP7711044B2 (ja) 2019-08-27 2020-08-26 コンプスタチン類似体及びその医学的使用

Country Status (14)

Country Link
US (1) US20220306695A1 (https=)
EP (2) EP4021921A1 (https=)
JP (1) JP7711044B2 (https=)
KR (1) KR20220066287A (https=)
CN (1) CN114630836A (https=)
AU (1) AU2020338688A1 (https=)
BR (1) BR112022003760A2 (https=)
CA (1) CA3148536A1 (https=)
CO (1) CO2022003556A2 (https=)
ES (1) ES3049784T3 (https=)
IL (1) IL290858A (https=)
MX (1) MX2022002433A (https=)
TW (1) TW202128731A (https=)
WO (1) WO2021037942A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2020128624A (ru) 2018-02-27 2022-03-28 Зп Спв 3 К/С Аналоги компстатина и их медицинское применение
IL299870A (en) * 2020-07-16 2023-03-01 Zp Spv 3 K/S Complement factor C3 inhibitors and their medical uses
CA3204051A1 (en) 2021-01-20 2022-07-28 Brian Lian Compositions and methods for the treatment of metabolic and liver disorders
JP7642830B2 (ja) 2021-09-15 2025-03-10 バイキング・セラピューティクス・インコーポレイテッド 代謝及び肝臓障害の処置のための組成物及び方法
WO2023048151A1 (ja) * 2021-09-22 2023-03-30 塩野義製薬株式会社 ウイルス増殖阻害活性を有する環状ペプチド
CN120359233A (zh) * 2022-11-24 2025-07-22 阿麦达斯制药美国有限责任公司 用于基于载体的疗法的坎普他汀类似物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6319897B1 (en) 1996-03-13 2001-11-20 John D. Lambris Peptides which inhibit complement activation
IL128332A0 (en) 1996-08-30 2000-01-31 Novo Nordisk As GLP-1 derivatives
AU723268B2 (en) 1996-09-09 2000-08-24 Zealand Pharma A/S Improved solid-phase peptide synthesis and agent for use in such synthesis
WO1999013899A1 (en) 1997-09-17 1999-03-25 Trustees Of The University Of Pennsylvania Peptides and peptidomimetics for inhibiting complement activation
US6451987B1 (en) 1999-03-15 2002-09-17 Novo Nordisk A/S Ion exchange chromatography of proteins and peptides
CZ20013018A3 (cs) 1999-03-17 2002-02-13 Novo Nordisk A/S Způsob pro acylování aminoskupiny peptidu nebo proteinu a sloučenina
PT1549333E (pt) 2002-09-20 2012-01-03 Univ Pennsylvania Análogos de compstatina com actividade melhorada
EP2662089A3 (en) 2005-10-08 2014-02-19 Potentia Pharmaceuticals, Inc. Compstatin and analogs thereof for eye disorders
CN102977191B (zh) 2005-11-28 2016-08-10 宾夕法尼亚州大学理事会 有效的c3补体抑制素类似物
WO2008153963A1 (en) 2007-06-08 2008-12-18 The Trustees Of The University Of Pennsylvania Structure of compstatin-c3 complex and use for rational drug design
EP2340028B1 (en) * 2008-09-30 2018-06-27 The Trustees Of The University Of Pennsylvania Method of inhibiting biomaterial-induced procoagulant activity using complement inhibitors
CA2813049A1 (en) 2010-09-23 2012-03-29 The Trustees Of The University Of Pennsylvania Modified compstatin with improved stability and binding properties
CA2847862C (en) 2011-09-07 2021-01-12 The Trustees Of The University Of Pennsylvania Compstatin analogs with improved pharmacokinetic properties
US9512180B2 (en) 2012-12-19 2016-12-06 The Regents Of The University Of California Compstatin analogs
AR099569A1 (es) * 2014-02-28 2016-08-03 Novo Nordisk As Derivados de insulina y los usos médicos de estos
US20180057538A1 (en) * 2016-08-26 2018-03-01 The Regents Of The University Of California Potent and highly soluble pegylated compstatin peptides
RU2020128624A (ru) * 2018-02-27 2022-03-28 Зп Спв 3 К/С Аналоги компстатина и их медицинское применение

Similar Documents

Publication Publication Date Title
JP2022545916A5 (https=)
RU2020128624A (ru) Аналоги компстатина и их медицинское применение
JP6185920B2 (ja) ポリミキシン誘導体
RU2428429C2 (ru) Пептидные антибиотики и способы их получения
EP2894160B1 (en) Compound with effects of thrombolysis, free radical scavenging and thrombus-targeting as well as preparation method and use thereof
JP2020073481A5 (https=)
ES2292558T3 (es) Kahalalido f y compuestos relacionados.
JPS6351159B2 (https=)
CN101693736A (zh) 新的肽
US5386011A (en) Hexapeptide anaphylatoxin-receptor ligands
JP2023538807A5 (https=)
JP2009532384A5 (https=)
PT100563A (pt) Ligandos tri-tetra- e pentapeptidicos do receptor da anafilatoxina, terminalmente modificados, composicoes farmaceuticas e uso
US5387671A (en) Hexa- and heptapeptide anaphylatoxin-receptor ligands
DE69528531T2 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
US5223485A (en) Anaphylatoxin-receptor ligands
PL165133B1 (pl) Sposób wytwarzania nowych peptydów PL PL PL PL PL PL
EP2010203A2 (en) Macrocyclic peptides and methods for making and using them
CA2127330C (en) Motilin-like polypeptides with gastrointestinal motor stimulating activity
JPH04501259A (ja) Crf拮抗体
HUT75538A (en) Oligopeptides derived from c-reactive protein fragments
AU718320B2 (en) Peptide derivatives
HU229220B1 (hu) Humán növekedési hormont felszabadító hormon-analógok
WO2014191392A1 (en) New cationic amino acids, pharmaceutical compositions containing the same and their use for the treatment of bacterial infections
JP2627262B2 (ja) 新規トリペプチド化合物